Published in Pharma Law Weekly, December 6th, 2011
Our investigation concerns possible breaches of fiduciary duty and other violations of law related to the approval of the transaction by Company's board of directors; in particular, whether the Company undertook a fair process to obtain fair consideration for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly